Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kea Franz

Showing results (11-20 of 66) with videos related to

Pageof 7
Sort By:
Brain Tumor Pathology|November 4, 2010
Proton magnetic resonance spectroscopic imaging in pediatric low-grade gliomasLuciana Porto, Matthias Kieslich, Kea Franz, et al.
Journal of Neuro-Oncology|October 8, 2010
Stripe-like increase of rCBV beyond the visible border of glioblastomas: site of tumor infiltration growing after neurosurgeryStella Blasel, Kea Franz, Hanns Ackermann, et al.
Neurosurgical Review|February 13, 2008
Pineal parenchymal tumor of intermediate differentiation: diagnostic pitfalls and discussion of treatment options of a rare tumor entityChristian Senft, Andreas Raabe, Elke Hattingen, et al.
NMR in Biomedicine|June 15, 2007
Myo-inositol: a marker of reactive astrogliosis in glial tumors?Elke Hattingen, Peter Raab, Kea Franz, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|November 1, 2011
Radiochemotherapy with temozolomide for patients with glioblastoma. Prognostic factors and long-term outcome of unselected patients from a single institutionJohanna Gerstein, Kea Franz, Joachim P Steinbach, et al.
Clinical Neuroradiology|October 7, 2017
In vivo Metabolic Profiles as Determined by <sup>31</sup>P and short TE <sup>1</sup>H MR-Spectroscopy : No Difference Between Patients with IDH Wildtype and IDH Mutant GliomasKatharina J Wenger, Elke Hattingen, Kea Franz, et al.
Magma (New York, N.Y.)|October 3, 2008
1H MR spectroscopic imaging with short and long echo time to discriminate glycine in glial tumoursElke Hattingen, Heinrich Lanfermann, Johanna Quick, et al.
Journal of Magnetic Resonance Imaging : JMRI|February 7, 2017
Intracellular pH measured by <sup>31</sup> P-MR-spectroscopy might predict site of progression in recurrent glioblastoma under antiangiogenic therapyKatharina J Wenger, Elke Hattingen, Kea Franz, et al.
Journal of Neurosurgical Anesthesiology|May 20, 2011
Feasibility of intraoperative MRI guidance for craniotomy and tumor resection in the semisitting positionChristian Senft, Bernd Schoenes, Thomas Gasser, et al.
Journal of Neuro-Oncology|January 18, 2012
Risk of ischemia in glioma surgery: comparison of first and repeat proceduresStephan Dützmann, Florian Geßler, Andrea Bink, et al.
Pageof 7

Showing results (11-20 of 66) with videos related to

Sort By:
Pageof 7
Brain Tumor Pathology|November 4, 2010
Proton magnetic resonance spectroscopic imaging in pediatric low-grade gliomasLuciana Porto, Matthias Kieslich, Kea Franz, et al.
Journal of Neuro-Oncology|October 8, 2010
Stripe-like increase of rCBV beyond the visible border of glioblastomas: site of tumor infiltration growing after neurosurgeryStella Blasel, Kea Franz, Hanns Ackermann, et al.
Neurosurgical Review|February 13, 2008
Pineal parenchymal tumor of intermediate differentiation: diagnostic pitfalls and discussion of treatment options of a rare tumor entityChristian Senft, Andreas Raabe, Elke Hattingen, et al.
NMR in Biomedicine|June 15, 2007
Myo-inositol: a marker of reactive astrogliosis in glial tumors?Elke Hattingen, Peter Raab, Kea Franz, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|November 1, 2011
Radiochemotherapy with temozolomide for patients with glioblastoma. Prognostic factors and long-term outcome of unselected patients from a single institutionJohanna Gerstein, Kea Franz, Joachim P Steinbach, et al.
Clinical Neuroradiology|October 7, 2017
In vivo Metabolic Profiles as Determined by <sup>31</sup>P and short TE <sup>1</sup>H MR-Spectroscopy : No Difference Between Patients with IDH Wildtype and IDH Mutant GliomasKatharina J Wenger, Elke Hattingen, Kea Franz, et al.
Magma (New York, N.Y.)|October 3, 2008
1H MR spectroscopic imaging with short and long echo time to discriminate glycine in glial tumoursElke Hattingen, Heinrich Lanfermann, Johanna Quick, et al.
Journal of Magnetic Resonance Imaging : JMRI|February 7, 2017
Intracellular pH measured by <sup>31</sup> P-MR-spectroscopy might predict site of progression in recurrent glioblastoma under antiangiogenic therapyKatharina J Wenger, Elke Hattingen, Kea Franz, et al.
Journal of Neurosurgical Anesthesiology|May 20, 2011
Feasibility of intraoperative MRI guidance for craniotomy and tumor resection in the semisitting positionChristian Senft, Bernd Schoenes, Thomas Gasser, et al.
Journal of Neuro-Oncology|January 18, 2012
Risk of ischemia in glioma surgery: comparison of first and repeat proceduresStephan Dützmann, Florian Geßler, Andrea Bink, et al.
Pageof 7